CYPHERPUNK TECHNOLOGIES INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
CYPHERPUNK TECHNOLOGIES INC. (CYPH) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $2.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2025-05-13
- 2025-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.00K.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $7.00K.
- 2024-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $14.00K.
- 2024-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $24.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-03-31 | $2.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $7.00K 10-K · filed 2025-03-26 |
| 2024-09-30 | $14.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $24.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $37.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $6.00K 10-K · filed 2024-03-18 |
| 2023-09-30 | $12.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $20.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $30.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $41.00K 10-K · filed 2023-03-24 |
| 2022-09-30 | $57.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $73.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $7.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $10.00K 10-K · filed 2022-03-11 |
| 2021-09-30 | $6.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $11.00K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $19.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $28.00K 10-K · filed 2021-03-12 |
| 2020-09-30 | $39.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $52.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $68.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $86.00K 10-K · filed 2020-03-16 |
| 2019-09-30 | $108.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $134.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $162.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |